Cargando…

A primary immunodeficiency characterized by defective immunoglobulin class switch recombination and impaired DNA repair

Immunoglobulin class switch recombination (CSR) deficiencies are rare primary immunodeficiencies, characterized by a lack of switched isotype (IgG, IgA, or IgE) production, variably associated with abnormal somatic hypermutation (SHM). Deficiencies in CD40 ligand, CD40, activation-induced cytidine d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Péron, Sophie, Pan-Hammarström, Qiang, Imai, Kohsuke, Du, Likun, Taubenheim, Nadine, Sanal, Ozden, Marodi, Laszlo, Bergelin-Besançon, Anne, Benkerrou, Malika, de Villartay, Jean-Pierre, Fischer, Alain, Revy, Patrick, Durandy, Anne
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2007
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118580/ https://www.ncbi.nlm.nih.gov/pubmed/17485519 http://dx.doi.org/10.1084/jem.20070087

Ejemplares similares

Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis
por: Du, Likun, et al.
Publicado: (2012)

Immunoglobulin class-switch recombination deficiencies
por: Durandy, Anne, et al.
Publicado: (2012)

A regulatory role for the cohesin loader NIPBL in nonhomologous end joining during immunoglobulin class switch recombination
por: Enervald, Elin, et al.
Publicado: (2013)

Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination
por: Péron, Sophie, et al.
Publicado: (2008)

Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS syndrome”)
por: Pachlopnik Schmid, Jana, et al.
Publicado: (2012)

Disparate roles of ATR and ATM in immunoglobulin class switch recombination and somatic hypermutation
por: Pan-Hammarström, Qiang, et al.
Publicado: (2006)

Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination
por: Du, Likun, et al.
Publicado: (2008)

Editorial: Advances in Primary Immunodeficiency in Central-Eastern Europe
por: Pac, Malgorzata, et al.
Publicado: (2021)

Characterization of immunoglobulin mutations in humans with activation-induced cytidine deaminase deficiency
por: Longo, Nancy S, et al.
Publicado: (2007)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Editorial: Advances in primary immunodeficiencies (inborn errors of immunity) in Central-Eastern Europe, volume II
por: Pac, Malgorzata, et al.
Publicado: (2023)

Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination
por: Soulas-Sprauel, Pauline, et al.
Publicado: (2007)

Retinoids Regulate Survival and Antigen Presentation by Immature Dendritic Cells
por: Geissmann, Frédéric, et al.
Publicado: (2003)

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases
por: Kanegane, Hirokazu, et al.
Publicado: (2014)

The Primary Immunodeficiency Database in Japan
por: Mitsui-Sekinaka, Kanako, et al.
Publicado: (2022)

TACI triggers immunoglobulin class switching by activating B cells through the adaptor protein MyD88
por: He, Bing, et al.
Publicado: (2010)

An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex
por: Kracker, Sven, et al.
Publicado: (2015)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil
por: Kavli, Bodil, et al.
Publicado: (2005)

Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada
por: Gerth, William C, et al.
Publicado: (2014)

Non-homologous end joining in class switch recombination: the beginning of the end
por: Kotnis, Ashwin, et al.
Publicado: (2008)

The cohesin complex regulates immunoglobulin class switch recombination
por: Thomas-Claudepierre, Anne-Sophie, et al.
Publicado: (2013)

A Rose Amongst the Thorns: the Mission of the J Project in a Conflictual World
por: Maródi, László
Publicado: (2022)

Development of the Immune System
por: Durandy, Anne
Publicado: (1997)

Hyaluronidase facilitated subcutaneous immunoglobulin in primary immunodeficiency
por: Jolles, Stephen
Publicado: (2013)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
por: Poto, Remo, et al.
Publicado: (2023)

Switch Tandem Repeats Influence the Choice of the Alternative End-Joining Pathway in Immunoglobulin Class Switch Recombination
por: Oudinet, Chloé, et al.
Publicado: (2022)

Screening of functional and positional candidate genes in families with common variable immunodeficiency
por: Salzer, Ulrich, et al.
Publicado: (2008)

Human normal immunoglobulin in the treatment of primary immunodeficiency diseases
por: Wood, Philip
Publicado: (2012)

Principles of and Advances in Immunoglobulin Replacement Therapy for Primary Immunodeficiency
por: Berger, Melvin
Publicado: (2008)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency
por: Ducruet, Thierry, et al.
Publicado: (2011)

Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding
por: Morgan, Clare, et al.
Publicado: (2022)

Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching
por: Bothmer, Anne, et al.
Publicado: (2013)

Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?
por: Beudeker, Coco R., et al.
Publicado: (2022)

Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
por: Borte, Michael, et al.
Publicado: (2023)

The role of G-density in switch region repeats for immunoglobulin class switch recombination
por: Zhang, Zheng Z., et al.
Publicado: (2014)

Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse
Publicado: (1996)

DNA Polymerase η Is Involved in Hypermutation Occurring during Immunoglobulin Class Switch Recombination
por: Faili, Ahmad, et al.
Publicado: (2004)

RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair
por: Lescale, Chloé, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_etlr66o5n4sbm7ukn56mfggcqq